Katie S. Murray, DO, and Laura Bauer, a GU medical oncology nurse practitioner, both from NYU Langone Health, discuss their collaborative efforts at NYU in treating upper tract urothelial carcinoma using innovative mitomycin gel therapy and multidisciplinary care, highlighting patient impact and future directions in oncology practice.
Mitomycin Gel and UTUC Treatment: A Multidisciplinary Approach
By Katie S. Murray, DO, MS, Laura Bauer, NP - Last Updated: January 23, 2025Related Posts
Drs. Roupret and Houede dissect their research on the safety and efficacy of durvalumab with NAC for operable high-risk UTUC.
Patients who achieved a complete response after six doses of UGN-101 were followed up for 12 months after initial CR.
Dr. Hafron breaks down the most important updates in upper tract urothelial carcinoma from the LUGPA 2024 Annual Meeting.
Drs. Michael Whalen and Vincent Xu discuss potential alternative treatments for patients who are ineligible for chemotherapy.
Drs. Michael Whalen and Vincent Xu discuss their recent analysis of neoadjuvant chemotherapy utilization for UTUC.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.